INTRODUCTION {#sec1}
============

Necrotic enteritis toxin B (**NetB**)-producing *Clostridium perfringens* (**CP**) type A is the major etiologic agent for necrotic enteritis (**NE**) in broiler chickens (Cooper et al., [@bib4]; Zhou et al., [@bib41]). CP is a Gram-positive, spore-forming, anaerobic bacterium that is widely distributed in nature, and commonly found in soil, dust, animal production environments such as litter and contaminated feed, and in the gastrointestinal tract of animals and humans as a member of the normal (native) microbiota (Timbermont et al., [@bib31]; Miller et al., [@bib19]). The intestine of healthy birds typically contains approximately 10^4^ CFU of CP/g of digesta (McDevitt et al., [@bib18]). However, predisposing factors such as pre-existing damage to the intestinal epithelium by coccidia (*Eimeria* spp.), infectious bursal disease virus, high dietary levels of certain cereals and fish meal, disturbance to the normal intestinal flora, overcrowding, or a variety of management and climatic conditions (McDevitt et al., [@bib18]; Wu et al., [@bib39]) may favor proliferation of CP to reach a critical concentration of about 10^7^ to 10^9^ CFU/g of digesta (Williams, [@bib38]). At this concentration, CP produces toxins that induce mucosal damage in the small intestine and ceca of chickens and turkeys, and results in clinical NE (Van Immerseel et al., [@bib33], [@bib34]).

Host--pathogen interaction in NE is complex and involves different components of the host immune system (Oh and Lillehoj, [@bib22]). In the chicken intestine, pathogenesis of CP begins with the bacteria penetrating the mucus barrier on the epithelial surface, followed by binding and attachment to epithelial cells. The mechanism by which bacterial pathogens (such as CP) bind to intestinal epithelial cells begins with the recognition and binding of pathogen-associated molecular patterns (**PAMPs**) by highly conserved pathogen recognition receptors, of which Toll-like receptors (**TLRs**) are the best characterized (Oh and Lillehoj, [@bib22]). It has been established that chickens have at least 10 TLRs comprising of cell surface-located TLR1a, TLR1b, TLR2a, TLR2b, TLR4, TLR5, TLR15, and intracellular endosome-located TLR3, TLR7, and TLR21 (Chen et al., [@bib3]). In particular, intestinal TLR2 is known to recognize peptidoglycans in Gram-positive bacteria such as CP, and its gene was upregulated in CP-challenged broiler chickens (Du et al., [@bib7]). Interactions between bacterial PAMPs and TLRs trigger a cascade of signaling events that result in the activation of dendritic cells and cellular responses, such as the differentiation of naive T helper (**Th**) cells into mature effector Th1, Th2, Th17, and Treg cells (St. Paul et al., [@bib29]; Oh and Lillehoj, [@bib22]). These signaling events culminate in the secretion of various cytokines, such as proinflammatory interleukin (**IL**)-1 by naïve Th cells, interferon-γ (**IFN- γ**) by Th1 cells, IL-13 by Th2 cells, IL-17 by Th17 cells, and transforming growth factor (**TGF**)-β and IL-10 by Treg cells (Cosmi et al., [@bib5]; Narsale et al., [@bib21]). Cytokines are effector molecules that communicate information between cells of the immune system, and the composition of cytokines in the microenvironment of an infection site determines the nature of the immune response affected.

Although some studies have studied the response of various cytokines to CP infection or NE disease in broiler chickens (Yitbarek et al., [@bib40]; Alizadeh et al., [@bib1]; Du et al., [@bib7]), robust data are needed especially since the induction of CP infection and NE disease is achieved through various challenge methods (Prescott et al., [@bib23]; Van Waeyenberghe et al., [@bib35]). It has been estimated that annually, NE costs the world poultry industry about \$6 billion (US), thereby making it an economically important disease (Wade and Keyburn, [@bib37]). Better understanding of the intestinal immune response to CP infection in commercial broiler chickens is important to enhance the design of more effective vaccines against NE. Our results clearly show that various cytokines and their associated immune function(s) are affected by CP infection. Plasma antibody levels to CP were also affected.

MATERIALS AND METHODS {#sec2}
=====================

All the procedures used in this study were approved by the Auburn University Institutional Animal Care and Use Committee.

Experimental Animals, Treatments, and Monitoring Chick Growth Performance {#sec2-1}
-------------------------------------------------------------------------

Broiler chicks used in this experiment were also utilized for the intestinal microbiota study reported by Fasina et al. ([@bib8]). Briefly, day-old male broiler chicks (400; Cobb x Cobb) were obtained from a commercial hatchery and subjected to a floor-pen trial at the Auburn University Poultry Research and Teaching Farm. Chicks were weighed, and randomly assigned to 4 treatments in a completely randomized design. Treatment 1 (**CX**) consisted of chicks not challenged with CP and fed an unmedicated corn-soybean meal (**SBM**) basal diet. Treatment 2 (**CM**) consisted of chicks not challenged with CP and fed a corn-SBM basal diet, with bacitracin methylene disalicylate (**BMD**) supplemented at 0.055 g/kg diet. Treatments 3 (**PCX**) and 4 (**PCM**) consisted of chickens challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks in treatments 1 and 2, respectively. The level of BMD antibiotic used in the CM and PCM diets was subtherapeutic and served as a prophylactic. Each treatment consisted of 4 replicate pens with 25 chickens per pen. The floor of each pen was covered with fresh pine shavings that served as litter. Experimental diets were formulated to meet the recommendations of the National Research Council ([@bib21a]), and chickens were allowed ad libitum access to feed and water throughout the experiment. Duration of the experiment was 42 d. Growth performance of chickens was monitored throughout the experiment by recording body weight and feed conversion ratio on day 21 and 42.

CP Challenge and Confirmation of CP Infection {#sec2-2}
---------------------------------------------

A cocktail of 3 CP (type A) strains obtained from commercial broiler chicken flocks were used to prepare a composite CP inoculum daily on day 14, 15, and 16 of the experiment, as described by Fasina et al. ([@bib8]). The concentration of CP cells in the inoculum prepared each day was estimated spectrophotometrically at 600 nm with the aid of a standard curve. Actual CP concentration in the inoculum was confirmed by colony-plating on tryptose sulfite cycloserine agar (Oxoid Ltd, Hampshire, UK) plates, incubating the plates anaerobically at 37°C for 18 h, and counting the numbers of black presumptive CP colonies. The concentration of CP cells in the inoculum prepared on day 14, 15, and 16 was 8.6 × 10^8^, 8.9 × 10^8^, and 9.1 × 10^8^ CFU/mL, respectively. Furthermore, the black presumptive colonies were confirmed as CP by the Rapid ID 32 A test kit (BioMerieux, Durham, NC). On each day of CP challenge (day 14, 15, and 16), a round-tipped animal feeding needle (15 G, 78 mm; Solomon Scientific, PA) attached to a repeating syringe (Popper & Sons, Inc., New Hyde Park, NY) was used to orally deliver 3 mL of the freshly prepared composite CP inoculum into the crop of each chick in the PCX and PCM treatments. Chickens in the control CX and CM treatments were mock-challenged with freshly prepared sterile fluid thioglycolate broth (**FTG**, Oxoid Ltd).

The establishment of CP infection was confirmed by estimating the intestinal CP concentration on day 13 (day 1 pre-challenge), 17 (day 1 post-challenge), 23 (day 7 post-challenge), and 37 (day 21 post-challenge) of experiment. On each day, 2 chicks were randomly taken from each pen (totaling 8 chicks per treatment) and euthanized by CO~2~ asphyxiation. Thereafter, the intestine of each chick was aseptically excised, and a 15-cm long segment from the mid-jejunum to the mid-ileum was removed, placed in a Whirl-Pak sample bag (Nasco, Fort Atkinson, WI), and kept on ice until time for transportation to the laboratory. From each sample, approximately 5 g of intestinal digesta was weighed and transferred into 10 mL of anaerobic FTG broth in a sterile filter-containing Whirl-Pak bag (Nasco, Fort Atkinson, WI). The Whirl-Pak filter bag was stomached for 30 s (Stomacher 400 Circulator, Seward Limited, London, UK), after which 1 mL of the resulting filtrate was transferred into a test tube containing 9 mL of FTG broth that was subjected to a 10-fold serial dilution. The dilutions for each sample were spiral-plated on tryptose sulfite cycloserine agar, and then incubated anaerobically at 37°C for 24 h. The number of characteristic black presumptive CP colonies was then counted for each sample. The CP concentration was expressed as log~10~ CFU/g intestinal content. Results obtained affirmed that CP infection was successfully established in PCX and PCM chicks (Table [1](#tbl1){ref-type="table"}).

###### 

Intestinal concentration of *C. perfringens* in broiler chicks.^[1](#tb1fn2){ref-type="table-fn"}^

                         Log~10~ CFU of *C. perfringens*/g intestinal contents                                       
  ---------------------- ------------------------------------------------------- ------------------ ---------------- ------------------
  CX                     ND                                                      1.26 ± 0.01^b^     2.03 ± 0.29^c^   3.09 ± 0.77^a,b^
  CM                     ND                                                      1.26 ± 0.01^b^     1.43 ± 0.16^c^   1.47 ± 0.19^b^
  PCX                    ND                                                      4.19 ± 0.69^a^     4.37 ± 0.38^a^   3.89 ± 0.53^a^
  PCM                    ND                                                      2.85 ± 0.75^a,b^   3.45 ± 0.24^b^   2.70 ± 0.33^a,b^
  Sources of variation   [Probability]{.ul}                                                                          
  Dietary treatment      ---                                                     NS                 0.0252           0.0170
  CP challenge           ---                                                     0.0007             \<0.0001         NS
  Diet x CP challenge    ---                                                     NS                 NS               NS

^a-c^Mean values bearing different superscript letters within a column are significantly different (*P* \< 0.05).

^1^Adapted from Fasina et al. ([@bib8]).

^2^Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal without antibiotic supplementation; Treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with *C. perfringens* on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively.

^3^Baseline intestinal *C. perfringens* concentration determined at 1 d pre-challenge (i.e., day 13 of experiment). ND = not detectable, with the detection limit of the recovery assay being ≥ 0.10 Log~10~ CFU of *C. perfringens*/g intestinal contents.

PC = post-challenge; CP = *Clostridium perfringens;* NS = not significant.

Collection of Intestinal Tissue and Blood for Downstream Analysis, and Lesion Scoring {#sec2-3}
-------------------------------------------------------------------------------------

Intestinal tissue sections were collected on day 1 and 7 post-CP challenge for the determination of expression levels of proinflammatory, Th1, Th2, and cytokine genes. On each day, 2 chickens were randomly taken from each pen (totaling 8 chickens per treatment) and euthanized by CO~2~ asphyxiation. Thereafter, the small intestine of each chicken was aseptically excised and placed on ice. The mid-portion of the jejunum (from the pancreo-biliary ducts to the yolk stalk) was cut, rinsed in cold saline (0.9% NaCl) to remove gut contents, placed in a DNase- and RNase-free cryovial, snap-frozen in liquid N~2~, and kept at --70°C until time for analysis. The cecal tonsil was collected only on day 7 post-CP challenge, and frozen as previously described for jejunal segments. For lesion scoring, the duodenum of each chicken sampled was scored on day 1 post-challenge. Assessing the presence and severity of necrotic lesions in the presence of CP infection indicates if a subclinical or clinical NE disease has been established in the birds (McDevitt et al., [@bib18]). Accordingly, the presence of macroscopic lesions in the duodenum was assessed using a scale described by Prescott et al. ([@bib24]). Lesions were scored on a 0 to 4 scale, where 0 = no apparent lesions, 1 = thin, friable small intestine, 2 = focal necrosis, ulceration, or both, 3 = patchy necrosis, and 4 = severe, extensive mucosal necrosis.

On day 14 post-CP challenge, 2 chickens were randomly selected from each pen (totaling 8 chickens/treatment) and bled. Specifically, a 23-G needle (1 inch long) attached to a 5 mL syringe pre-coated with ethylenediaminetetraacetic acid (**EDTA**) was used to collect 3 mL of blood from the brachial vein of each chick. Thereafter, the needle was removed, and the syringe was inverted 3 times to ensure adequate mixing of blood with the EDTA anticoagulant. Each blood sample was then transferred into an appropriately labeled 15 mL plastic centrifuge tube and kept on ice until all birds were bled. Tubes were then transported to the laboratory and centrifuged at 4,000 × g for 10 min. The resulting supernatant, which is the plasma, was decanted into appropriately labeled 1.5 mL microcentrifuge tubes and stored at −70°C until time to determine CP-specific antibody levels.

RNA Extraction and cDNA Synthesis for Gene Expression Analyses {#sec2-4}
--------------------------------------------------------------

Jejunal tissue and cecal tonsils (30 μg each) were homogenized with a MiniBeadbeater-96^TM^ (Biospec Products, Inc., Bartlesville, OK). Total RNA was isolated from homogenates using RNeasy mini kit (Qiagen, Waltham, MA) following the manufacturer\'s protocol, and then eluted in 100 μL RNase-free water. To determine RNA concentration in each sample, a 1:100 dilution of the eluted RNA in 10 mM Tris-HCl (pH 7.5) was prepared and measured spectrophotometrically at 260 nm. RNA purity was determined by measuring the ratio of absorbance readings of RNA samples at 260 and 280 nm (i.e., A260/A280). The A260/A280 ratio for all RNA samples was between 1.8 and 2.0, indicating that the RNA samples are pure. Remaining RNA for each sample were then stored at --70°C until time for cDNA synthesis.

Synthesis of cDNA was done as previously described by Hong et al. ([@bib11]). Briefly, 5 μg of each RNA sample was treated with 1.0 unit of DNase I and 1.0 μL of 10X reaction buffer (Sigma), and then incubated for 15 min at room temperature. Stop solution (1.0 μL) was then added to inactivate DNase I, and the mixture was heated at 70°C for 10 min. RNA was reverse transcribed using StrataScript first-strand synthesis system (Stratagene, La Jolla, CA) according to the manufacturer\'s recommendations. For each sample, 5.0 μg of RNA was combined with 10X first strand buffer, 1.0 μL of oligo(dT) primer (5 μg/μL), 0.8 μL of dNTP mix (25 mM of each dNTP), and RNase-free water to total volume 19 μL. The mixture was incubated at 65°C for 5 min, cooled to room temperature, and 50 units of StrataScript reverse transcriptase was added. The mixture was then incubated at 42°C for 1 h, and the reaction stopped by heating at 70°C for 5 min.

Quantitative Real-Time RT-PCR {#sec2-5}
-----------------------------

The oligonucleotide primers used for quantitative RT-PCR analyses of chicken cytokines and GAPDH housekeeping gene are listed in Table [2](#tbl2){ref-type="table"}. Briefly, the Mx3000P system and Brilliant SYBR Green QPCR master mix (Stratagene) were used in the amplification and detection of equivalent amounts of total RNA from each sample as described by Hong et al. ([@bib11]). Standard curves were generated using log10 diluted standard RNA, and levels of individual transcripts were normalized to those of GAPDH analyzed by the Q-gene program (Muller et al., [@bib20]). Each analysis was performed in triplicate. To normalize RNA levels between samples within an experiment, the mean threshold cycle (Ct) values for the amplification products were calculated by pooling values from all samples in that experiment.

###### 

Sequence of primers used for real-time quantitative RT-PCR.^[1](#tb2fn1){ref-type="table-fn"}^

           Primer sequence (5΄-3΄)                                             
  -------- ------------------------------ ------------------------------ ----- ----------
  GAPDH    5΄-GGTGGTGCTAAGCGTGTTAT-3΄     5΄-ACCTCTGTCATCTCTCCACA-3΄     264   K01458
  IL-1β    5΄-TGGGCATCAAGGGCTACA-3΄       5΄-TCGGGTTGGTTGGTGATG-3΄       244   Y15006
  IL-17    5΄-CTCCGATCCCTTATTCTCCTC-3΄    5΄-AAGCGGTTGTGGTCCTCAT-3΄      292   AJ493595
  IFN-γ    5΄-AGCTGACGGTGGACCTATTATT-3΄   5΄-GGCTTTGCGCTGGATTC-3΄        259   Y07922
  IL-2     5΄-TCTGGGACCACTGTATGCTCT-3΄    5΄-ACACCAGTGGGAAACAGTATCA-3΄   256   AF000631
  IL-13    5΄-CCAGGGCATCCAGAAGC-3΄        5΄-CAGTGCCGGCAAGAAGTT-3΄       256   AJ621735
  IL-10    5΄-CGGGAGCTGAGGGTGAA-3΄        5΄-GTGAAGAAGCGGTGACAGC-3΄      272   AJ621614
  TGF-β4   5΄-CGGGACGGATGAGAAGAAC-3΄      5΄-CGGCCCACGTAGTAAATGAT-3΄     258   M31160

^1^Adapted from Hong et al. ([@bib11]) and Li et al. ([@bib13]).

Enzyme-Linked immunosorbent Assay (ELISA) {#sec2-6}
-----------------------------------------

Frozen plasma samples were thawed on ice and subjected to an enzyme-linked immunosorbent assay (**ELISA**) procedure for the determination of antibody levels to recombinant NetB CP protein as described by Lee et al. ([@bib12]). Briefly, flat-bottom, 96-well microtiter plates (Corning Costar, Corning, NY) were coated overnight at 4°C with 2.5 μg/well of purified recombinant NetB toxin protein in 0.1 M carbonate buffer, pH 9.6. The plates were washed twice with PBS containing 0.05% Tween 20 (PBS-T), blocked for 1 h at 22°C with 100 μL/well of PBS containing 1% bovine serum albumin, washed with PBS-T, and incubated for 2 h at 22°C with 100 μL/well of appropriately diluted plasma samples. Thereafter, plates were washed with PBS-T, incubated for 2 h at 22°C with peroxidase-conjugated goat anti-chicken IgY secondary antibody (1:1000; Sigma), and for 10 min with 0.01% tetramethylbenzidine substrate (Sigma) in 0.05 M phosphate-citrate buffer, pH 5.0. Bound antibodies were detected by measuring optical density at 450 nm (OD~450~) using a microplate reader (Bio-Rad).

Statistical Analyses {#sec2-7}
--------------------

All quantitative RT-PCR cytokine gene expression data and antibody ELISA data were subjected to 1-way ANOVA using the general linear models (**GLM**) procedure of SAS (SAS Inc., [@bib27]). Significant differences among means were determined using the Duncan option of the GLM procedure as a post hoc test, and statements of statistical significance were based upon *P* \< 0.05. Data are presented as means ± SEM.

RESULTS {#sec3}
=======

There were no differences (*P* \> 0.05) in the body weight and feed conversion ratio of birds in all treatments as previously reported by Fasina et al. ([@bib8]). However, the establishment of CP infection in experimental chickens was confirmed, with the treatment groups exposed to CP having a 1.5 to 2-fold higher CP levels (*P* \< 0.05) compared to the non-exposed groups (Table [1](#tbl1){ref-type="table"}; Fasina et al., [@bib8]). In addition, macroscopic lesion scores for treatments exposed to CP challenge were numerically higher (PCX = 1.52; PCM = 1.25) compared to their corresponding controls (CX = 1.22; CM = 0.90), and these differences approached significance (*P* = 0.0791). Presence of CP infection was further corroborated by the higher mortality observed in the treatment groups exposed to CP (*P* = 0.0003; PCX = 4.25%; PCM = 5.50), compared to their corresponding controls (CX = 1.25%; CM = 1.25%). Total mortality in this experiment was 12.25%.

Intestinal Cytokine Gene Expression {#sec3-1}
-----------------------------------

The expression levels of genes of proinflammatory IL-1β, Th1 cytokines (IFN-γ; IL-2), Th2 cytokines (IL-13), Th17 cytokine (IL-17), and Treg cytokines (IL-10 and TGF-β) are presented in Figures [1](#fig1){ref-type="fig"} to [7](#fig7){ref-type="fig"}. On day 1 post-challenge, IL-1β gene was not upregulated in the jejunum of CP-challenged PCX and PCM treatments (Figure [1A](#fig1){ref-type="fig"}; *P* \> 0.05). However, by day 7 post-challenge, expression of IL-1β gene was upregulated in the jejunum of PCM treatment (*P* \< 0.05), compared to the control (unchallenged) CX and CM treatments (Figure [1B and C](#fig1){ref-type="fig"}). Expression of IFN-γ gene approached downregulation (*P* = 0.0632) on day 1 post-challenge in the jejunum of challenged PCX and PCM treatments (Figure [2A](#fig2){ref-type="fig"}). However, this apparent downregulation was not sustained through day 7 post-challenge in the jejunum (Figure [2B](#fig2){ref-type="fig"}) and cecal tonsils (Figure [2C](#fig2){ref-type="fig"}). Another interesting observation on day 7 was that the unmedicated treatments (CX and PCX) had higher expression levels of IFN-γ gene (*P* \< 0.05) compared to the medicated BMD-treated CM and PCM (Figure [2B](#fig2){ref-type="fig"}). IL-2 was downregulated in the jejunum of PCX and PCM treatments on day 7 post-challenge, compared to their corresponding control treatments CX and CM (*P* \< 0.05; Figure [3A](#fig3){ref-type="fig"}). A similar trend was observed in the cecal tonsils (Figure [3B](#fig3){ref-type="fig"}). In the jejunum, IL-13 was upregulated in the challenged PCM treatment on day 1 post-challenge, compared to the control CX and CM treatments (*P* \< 0.05; Figure [4A](#fig4){ref-type="fig"}), and this upregulation diminished by day 7 post-challenge in the jejunum (Figure [4B](#fig4){ref-type="fig"}), but was sustained in the cecal tonsil (Figure [4C](#fig4){ref-type="fig"}). IL-17 gene was significantly upregulated (*P* \< 0.05) in the jejunum and cecal tonsils of challenged PCX and PCM treatments on day 7 post-challenge (Figure [5A and B](#fig5){ref-type="fig"}).

![Expression of IL-1β gene in the intestine and cecal tonsils of *Clostridium perfringens* (CP)-challenged broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; Treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig1){#fig1}

![Expression of IFN-γ gene in the intestine and cecal tonsils of *Clostridium perfringens* (CP)-challenged broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig2){#fig2}

![Expression of IL-2 gene in the intestine and cecal tonsils of *Clostridium perfringens* (CP)-challenged broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig3){#fig3}

![Expression of IL-13 gene in the intestine and cecal tonsils of *Clostridium perfringens* (CP)-challenged broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig4){#fig4}

![Expression of IL-17 gene in the intestine and cecal tonsils of *Clostridium perfringens* (CP)-challenged broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig5){#fig5}

For Treg cytokines, there was no consistent trend in the expression level of IL-10 between the non-medicated (CX and PCX) and medicated treatments (CM and PCM). Specifically, IL-10 was upregulated (*P* \< 0.05) in the jejunum of PCX compared to CX, but was downregulated (*P* \< 0.05) in PCM compared to CM (Figure [6A](#fig6){ref-type="fig"}). A similar trend was observed for cecal tonsils, except that the differences in IL-10 expression between treatments were not significant (*P* \> 0.05; Figure [6B](#fig6){ref-type="fig"}). Among the medicated treatments, TGF-β4 was significantly upregulated (*P* \< 0.05) in the jejunum of PCM treatment compared to CM (Figure [7A](#fig7){ref-type="fig"}), while TGF-β4 expression level was similar for the unmedicated CX and PCX at day 1 post-challenge. However, by day 7 post-challenge, the expression levels of TGF-β4 gene in both PCX and PCM treatments were consistently downregulated in the jejunum (Figure [7B](#fig7){ref-type="fig"}; *P* \> 0.05) and cecal tonsils (Figure [7C](#fig7){ref-type="fig"}; *P* \< 0.05) compared to their corresponding controls.

![Expression of IL-10 gene in the intestine and cecal tonsils of *Clostridium perfringens* (CP)-challenged broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig6){#fig6}

![Expression of TGF-β4 gene in the intestine and cecal tonsils of *Clostridium perfringens* (CP)-challenged broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig7){#fig7}

The expression of most of the cytokine genes evaluated in this study followed a similar trend for both BMD-free (CX and CPX) and BMD-supplemented (CM and PCM) treatments. In contrast, the expression of IFN-γ in the jejunum was higher (*P* \< 0.05) for the BMD-free treatments on day 7 post-challenge, compared to the BMD-supplemented treatments. The reverse was observed for IL-2 in the cecal tonsils. Specifically, the expression level of IL-2 in the cecal tonsils was lower (*P* \< 0.05) for BMD-free treatments compared to BMD-supplemented treatment.

In summary, the results of cytokine gene expression in this study indicated that CP-induced subclinical NE activated inflammatory immune response via Th2 and Th17 cytokines. This is because, proinflammatory IL-1β was upregulated, IFN-γ (Th1 cytokine) was not affected, IL-2 (Th1 cytokine) was downregulated, IL-13 (Th2 cytokine) was upregulated, IL-17 (Th17 cytokine) was upregulated, IL-10 (Treg cytokine) response was pleiotropic, and anti-inflammatory TGF-β4 was downregulated. In addition, humoral adaptive immune response indicated that higher levels of antibodies to CP recombinant proteins were detected in the plasma of challenged chicks (PCX and PMX; *P* \< 0.05) compared to the control chicks in CX and CM (Figure [8](#fig8){ref-type="fig"}).

DISCUSSION {#sec4}
==========

An experiment was conducted to determine the expression levels of selected proinflammatory, Th1, Th2, Th17, and Treg cytokine genes in the jejunum and cecal tonsils of CP-challenged broiler chickens. The CP-challenged chickens used in this study were confirmed to have an established CP infection (Table [1](#tbl1){ref-type="table"}), without an apparent effect on growth performance (Fasina et al., [@bib8]). Similarly, Du et al. ([@bib7]) found no effect on growth performance of broiler chickens challenged with CP between 14 and 20 d of age, even though changes in cytokine expression and an elevated mucosal secretory IgA were observed.

Assessment of mortality levels along with the presence and severity of focal intestinal macroscopic lesions are accepted indicators of an established subclinical or clinical NE disease in the presence of CP infection in broiler chickens (McDevitt et al., [@bib18]; Prescott et al., [@bib23]; Smyth, [@bib28]; Hofacre et al., [@bib10]). The moderately high total mortality (12.25%) in this experiment, along with the relatively low lesion scores observed for the CP-challenged PCX (1.52) and PCM (1.25) treatments are indicative of an established subclinical NE in the PCX and PCM chickens. It is not uncommon for broiler chickens experiencing subclinical NE to have low levels of focal macroscopic lesions in the small intestine (Lovland and Kaldhusdal, [@bib15]; Van Immerseel et al., [@bib33]). In a similar study, Li et al. ([@bib14]) orally challenged broiler chickens with CP (2.0 × 10^8^ CFU/mL, 1.0 mL per bird) or sterile media from day 14 to 20 of experiment. They assessed intestinal lesions on day 1 post-challenge and found that CP-challenged birds had a lesion score of 2.0, while no lesions were found in the control birds (*P* = 0.003). In addition, they reported that the CP-challenged birds had 20% mortality, while no birds died in the control group (*P* = 0.061). Broiler flocks that have clinical NE may experience up to 45% mortality (McDevitt et al., [@bib18]; Hofacre et al., [@bib10]). Accordingly, in this study, CP infection was successfully established in CP-challenged PCX and PCM birds as indicated by their moderately high mortality and low lesion scores. We further speculate that the CP infection perhaps induced subclinical NE in PCX and PCM birds.

The diverse functions and characteristics of cytokines and immunoregulatory molecules secreted by the different subsets of T-helper cells have been described by various authors (Romagnani, [@bib26]; Vignali et al., [@bib36]; Cosmi et al., [@bib5]; Oh and Lillehoj, [@bib22]; Narsale et al., [@bib21]). In general, when activated by macrophages and/or dendritic cells, naïve T-helper cells characteristically produce IL-1 and other pro-inflammatory cytokines that promote their differentiation into Th1, Th2, Th17, or Treg cells. In this study, IL-1β was upregulated in the jejunum and cecal tonsils of CP-challenged chickens, indicating that CP infection induced inflammation. Activated Th1 cells principally produce IFN- γ, tumor necrosis factor-α, and sometimes IL-2, and are important in providing protection against intracellular pathogens through activation of phagocytes and the production of opsonizing and complement-fixing antibodies (Cosmi et al., [@bib5]). In this study, IFN-γ was not affected, while IL-2 was significantly downregulated in the jejunum. This may indicate that Th1 cells play limited role in mounting immune response to intestinal CP during the early stage of infection.

Th2 cells function to promote acute and chronic inflammatory responses against a variety of pathogens, particularly helminths, and characteristically produce IL-4 and IL-13 cytokines upon activation (Cosmi et al., [@bib5]; Narsale et al., [@bib21]). In this study, IL-13 was upregulated in the jejunum and cecal tonsils of CP-challenged chickens, indicating that Th2 cells are involved in mediating immune response to intestinal CP. Th17 cells are primarily involved in the clearance of extracellular bacteria and fungi through the activation of granulocytes, and they characteristically produce IL-17 and IL-22 cytokines when activated. In this study, IL-17 was upregulated, indicating its involvement in mounting the immune response to intestinal CP. The Treg cells primarily produce a variety of anti-inflammatory cytokines such as TGF-β, IL-10, and IL-35. In this study, TGF-β was downregulated in the cecal tonsils of CP-challenged chicks on day 7 (*P* \< 0.05; Figure [7C](#fig7){ref-type="fig"}), but not in the jejunum. On the other hand, IL-10 response was inconsistent (Figure [6A and B](#fig6){ref-type="fig"}), reinforcing its pleiotropic and contradictory effect on the immune system (Mannino et al., [@bib16]). Furthermore, the higher levels of plasma antibodies to CP recombinant proteins observed in challenged chicks (PCX and PCM; *P* \< 0.05) confirm the involvement of the adaptive humoral immune system in the immune response to CP.

Previous work by Du et al. ([@bib7]) similarly reported an upregulation of the expression of IL-1β gene, and an elevated level of mucosal secretory IgA (*P* \< 0.05) in orally gavaged CP-challenged broiler chickens. Alizadeh et al. ([@bib1]) also reported similar results to ours for IFN-γ. Specifically, they found no difference (*P* \> 0.05) in the expression of IFN-γ in the ileum and cecal tonsils of broiler chickens on day 7 post-challenge. The similarity in IFN-γ results is interesting because Alizadeh et al. ([@bib1]) used a different CP challenge model in which the CP inoculum was added into the feed. In this study, CP challenge was done by orally gavaging the CP inoculum into the crop of the birds. Intestinal cytokine responses to CP infection can be modulated by differences in existing predisposable factors, differences in CP challenge methods used (oral gavage vs. inoculating CP in feed), differences in CP challenge dose administered to birds, and day of CP challenge (Prescott et al., [@bib23]).

An important observation in this study was the differences between BMD-free (CX and CPX) and BMD-supplemented (CM and PCM) treatments in the expression levels of jejunal IFN-γ and cecal IL-2 genes. BMD is one of the most commonly used antibiotic in commercial poultry production, and it is particularly active against Gram-positive bacteria such as CP (Marshall and Levy, [@bib17]; Crisol-Martínez et al., [@bib6]). Specifically, BMD suppresses the synthesis of the bacterial cell wall by inhibiting the lipid phosphorylase enzyme involved in the formation of late-stage peptidoglycan intermediates (Sugimoto et al., [@bib30]). Because intestinal microbial populations are interdependent, antibiotics may perturb the microbial composition, thereby altering immune responses (Ubeda and Pamer, [@bib32]). In this study, BMD may have triggered the differences in jejunal IFN-γ and cecal IL-2 gene expression levels by decreasing the number of Gram-positive bacteria, increasing the population of Enterobacteriaceae, and decreasing the number of Treg cells in the cecal tonsils (Atarashi et al., [@bib2]; Ubeda and Pamer, [@bib32]; Furusawa et al., [@bib9]).

![Plasma antibody (IgY) response to *Clostridium perfringens* (CP) infection in broiler chickens. Treatment 1 (CX) consisted of unchallenged chicks fed corn-soybean meal (SBM) basal only; treatment 2 (CM) consisted of unchallenged chicks fed corn-SBM basal into which bacitracin methylene disalicylate antibiotic was supplemented at 0.055 g/kg diet; treatments 3 (PCX) and 4 (PCM) consisted of chicks challenged with CP on 3 consecutive days (day 14, 15, and 16), and fed diets similar to those given to chicks treatments 1 and 2, respectively. Bars with different letters within each figure differ significantly (*P* \< 0.05).](pey390fig8){#fig8}

In summary, downregulation of TGF-β along with a concurrent upregulation in IL-1β, IL-13, and IL-17 indicates that CP-induced subclinical NE triggered an inflammatory immune response in the intestine of broiler chicks. In addition, the presence of higher levels of antibodies to recombinant CP proteins in challenged PCX and PCM treatments (*P* \< 0.05) compared to the unchallenged CX and CM corroborates the cytokine gene expression results. It was concluded that the signaling mechanisms underlying the inflammatory response to intestinal CP infection are probably modulated by Th2 and Th17 cells. Furthermore, these results suggest that any future strategies to reduce the negative effects of NE should be selected based on their potential to induce Th2 and Th17 cytokine secretion.
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